Locally-Controlled Activation of Chemotherapeutics by Palladium Catalysis as a Novel Anticancer Technology

Unciti-Broceta, Asier (Principal Investigator)
Brennan, Paul (Co-investigator)

Status	Finished
Effective start/end date	1/04/16 → 30/09/21

Funding

EPSRC: £1,323,824.00

12 Article

Targeted Molecular Construct for Bioorthogonal Theranostics of PD- L1-Expressing Cancer Cells
Chow, S. & Unciti-Broceta, A., 1 Jul 2022, In: JACS Au. 2, 7, p. 1747-1756
Research output: Contribution to journal › Article › peer-review

Open Access
File
A 5-FU precursor designed to evade anabolic and catabolic drug pathways and activated by Pd chemistry in vitro and in vivo
Adam, C., Bray, T., Perez-Lopez, A., Tan, E. H., Rubio Ruiz, B., Baillache, D., Houston, D. R., Salji, M. J., Leung, H. Y. & Unciti-Broceta, A., 13 Jan 2022, In: Journal of Medicinal Chemistry. 65, 1, p. 552-561
Research output: Contribution to journal › Article › peer-review

Open Access
File
Truly-biocompatible gold catalysis enables vivo-orthogonal intra-CNS release of anxiolytics
Ortega Liebana, M. C., Porter, N., Adam, C., Valero Grinan, T. M., Hamilton, L., Sieger, D., Becker, C. & Unciti-Broceta, A., 3 Nov 2021, (E-pub ahead of print) In: Angewandte Chemie.
Research output: Contribution to journal › Article › peer-review

Open Access
File